Letter by Nguyen and Doenst regarding article "Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart-failure prone rat".
Nguyen
Tien Dung
TD
Doenst
Torsten
T
D000818:Animals; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004285:Dogs; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage*; D051275:Glucose Transporter Type 4 / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D015398:Signal Transduction / Q000187:drug effects; D013599:Systole; D016277:Ventricular Function, Left / Q000187:drug effects*
D002317:Cardiovascular Agents; D051275:Glucose Transporter Type 4; D007328:Insulin; C495694:Slc2a4 protein, rat; D052216:Glucagon-Like Peptide 1; D051057:Proto-Oncogene Proteins c-akt